Physician

Nibash Budhathoki, MBBS

According to 2025 Medicare claims, Nibash Budhathoki, MBBS (NPI: 1861876526) practices hematology/oncology in the Sioux City, IA-NE-SD market, with the plurality of this provider's patient population coming from Woodbury, IA. This provider's primary affiliated billing organization is SIOUXLAND REGIONAL CANCER CENTER (NPI: 1114904604; TIN: 421411233) and primary practice location at 51101-1733. Budhathoki is affiliated with the NPG Health Collaborative LLC (ACO ID: A3287), Bryan Health Connect ACO, LLC (ACO ID: A4573), Avera Prairie View ACO (ACO ID: A4692), Caravan Health ACO 50 LLC (ACO ID: A5160), and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Budhathoki's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 785 traditional Medicare patients, billed 160,843 HCPCS/CPT codes, and received $3,706,235 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,734 prescription claims across 296 beneficiaries totaling $6,725,716 in drug costs, led by Revlimid (Lenalidomide). DME data shows 65 claims. Open Payments data shows 65 records totaling $1,171. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $43,672 to $6,725,716. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.9M$3.7M2021 Medicare payment: $829,295 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $2,718,991 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $3,658,437 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $3,706,235 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
202135041,306$829,295
2022775149,358$2,718,991
2023772176,930$3,658,437
2024785160,843$3,706,235

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$3.4M$6.7M2016 Drug cost: $43,672 (USD; Tot_Drug_Cst)2017 Drug cost: $20,396 (USD; Tot_Drug_Cst)2019 Drug cost: $1,448 (USD; Tot_Drug_Cst)2020 Drug cost: $28,950 (USD; Tot_Drug_Cst)2021 Drug cost: $506,158 (USD; Tot_Drug_Cst)2022 Drug cost: $2,742,835 (USD; Tot_Drug_Cst)2023 Drug cost: $5,421,433 (USD; Tot_Drug_Cst)2024 Drug cost: $6,725,716 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
201675367$43,672
201750267$20,396
2018N/RN/RN/R
2019N/R11$1,448
20202338$28,950
202191280$506,158
20222001,012$2,742,835
20232451,341$5,421,433
20242961,734$6,725,716

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$43K$85K2023 Medicare payment: $85,065 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $69,547 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023N/R90$85,065
2024N/R65$69,547

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more333632$87
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's521908$12
80053Blood test, comprehensive group of blood chemicals6111,327$10
36415Insertion of needle into vein for collection of blood sample5321,075$9
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count6571,496$8

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
RevlimidLenalidomide752,093$1,319,286
XtandiEnzalutamide712,106$800,887
PomalystPomalidomide27756$604,848
IbrancePalbociclib391,092$602,090
CalquenceAcalabrutinib Maleate381,140$411,957

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
J1561Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mgNN/R12$65,110
Q2052Services, supplies and accessories used in the home for the administration of intravenous immune globulin (ivig)NN/R11$3,626
J8700Temozolomide, oral, 5 mgNN/R17$416
Q0511Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day periodNN/R14$245
Q0512Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day periodNN/R11$151

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.65$1,171E.R. Squibb & Sons, L.L.C.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

Explore More Providers

FAQ

What Medicare data is available for Nibash Budhathoki, MBBS?

Tedicare shows public-source Medicare data for Nibash Budhathoki, MBBS (NPI 1861876526), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Nibash Budhathoki, MBBS have ACO affiliation data?

Nibash Budhathoki, MBBS is shown with ACO affiliation data for NPG Health Collaborative LLC (MSSP, ACO ID A3287), Bryan Health Connect ACO, LLC (MSSP, ACO ID A4573), Avera Prairie View ACO (MSSP, ACO ID A4692), Caravan Health ACO 50 LLC (MSSP, ACO ID A5160), and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Nibash Budhathoki, MBBS?

Nibash Budhathoki, MBBS is linked to SIOUXLAND REGIONAL CANCER CENTER (billing NPI 1114904604) in the available physician profile data.

Does Nibash Budhathoki, MBBS have Open Payments data?

Nibash Budhathoki, MBBS has 65 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.